|
| | Publication Year | Title | Author(s) |
| 681 | 1-May-2003 | A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. | Scott, Andrew M ; Wiseman, Greg; Welt, Sydney; Adjei, Alex; Lee, Fook-Thean; Hopkins, Wendie; Divgi, Chaitan R; Hanson, Lorelei H; Mitchell, Paul L R ; Gansen, Denise N; Larson, Steven M; Ingle, James N; Hoffman, Eric W; Tanswell, Paul; Ritter, Gerd; Cohen, Leonard S; Bette, Peter; Arvay, Lisa; Amelsberg, Andree; Vlock, Dan; Rettig, Wolfgang J; Old, Lloyd J |
| 682 | 17-Jan-2024 | A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2-) Advanced or Metastatic Breast Cancer. | Cescon, David W; Hilton, John; Morales Murilo, Serafín; Layman, Rachel M; Pluard, Timothy; Yeo, Belinda ; Park, In Hae; Provencher, Louise; Kim, Sung-Bae; Im, Young-Hyuck; Wyce, Anastasia; Krishnatry, Anu Shilpa; Hicks, Kirsty; Zhang, Qu; Barbash, Olena; Khaled, Ahmed; Horner, Thierry; Dhar, Arindam; Oliveira, Mafalda; Sparano, Joseph A |
| 683 | Feb-2022 | Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies. | Schöffski, Patrick; Tan, Daniel S W; Martín, Miguel; Ochoa-de-Olza, María; Sarantopoulos, John; Carvajal, Richard D; Kyi, Chrisann; Esaki, Taito; Prawira, Amy; Akerley, Wallace; De Braud, Filippo; Hui, Rina; Zhang, Tian; Soo, Ross A; Maur, Michela; Weickhardt, Andrew ; Krauss, Jürgen; Deschler-Baier, Barbara; Lau, Allen; Samant, Tanay S; Longmire, Tyler; Chowdhury, Niladri Roy; Sabatos-Peyton, Catherine A; Patel, Nidhi; Ramesh, Radha; Hu, Tiancen; Carion, Ana; Gusenleitner, Daniel; Yerramilli-Rao, Padmaja; Askoxylakis, Vasileios; Kwak, Eunice L; Hong, David S |
| 684 | 1-Apr-2004 | A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer. | Mitchell, Paul L R ; Basser, R L; Chipman, M; Grigg, Andrew P ; Mansfield, R; Cebon, Jonathan S ; Davis, Ian D; Appia, F; Green, M |
| 685 | Apr-2018 | Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study. | Lau, David K ; Tay, Rebecca Y; Yeung, Yvonne H ; Chionh, Fiona; Mooi, Jennifer; Murone, Carmel ; Skrinos, Effie; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C |
| 686 | Jul-2017 | Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma. | Abou-Alfa, Ghassan K; Blanc, Jean-Frederic; Miles, Steven; Ganten, Tom; Trojan, Jörg; Cebon, Jonathan S ; Liem, Andre K; Lipton, Lara; Gupta, Charu; Wu, Benjamin; Bass, Michael; Hollywood, Ellen; Ma, Jennifer; Bradley, Margaret; Litten, Jason; Saltz, Leonard B |
| 687 | Sep-2018 | Phosphate nephropathy: an avoidable complication of bowel preparation for colonoscopy. | Davies, Matthew R P ; Williams, David S ; Niewiadomski, Olga D |
| 688 | 3-Sep-2022 | Phylogenetic and Expression Analysis of Fos Transcription Factors in Zebrafish. | Kubra, Khadizatul ; Gaddu, Gurveer K ; Liongue, Clifford ; Heidary, Somayyeh ; Ward, Alister C ; Dhillon, Amardeep S ; Basheer, Faiza |
| 689 | Aug-2019 | A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases. | Arulananda, Surein; Parakh, Sagun ; Palmer, Jodie ; Goodwin, Mark D ; Andrews, Miles C; Cebon, Jonathan S |
| 690 | Mar-2017 | A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant | Davis, Ian D; Quirk, Juliet; Morris, Leone; Seddon, Lauren; Tai, Tsin Yee; Whitty, Genevieve; Cavicchiolo, Tina; Ebert, Lisa; Jackson, Heather; Browning, Judy; MacGregor, Duncan; Wittke, Frederick; Winkels, Gregor; Alex, Regina; Miloradovic, Lena; Maraskovsky, Eugene; Chen, Weisan; Cebon, Jonathan S |
| 691 | 1-Dec-2021 | A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer. | Wu, Yi-Long; Tsuboi, Masahiro; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S |
| 692 | 7-Jul-2022 | Plasma cell but not CD20-mediated B cell depletion protects from bleomycin-induced lung fibrosis. | Prêle, Cecilia M; Miles, Tylah; Pearce, David R; O'Donoghue, Robert J; Grainge, Chris; Barrett, Lucy; Birnie, Kimberly; Lucas, Andrew D; Baltic, Svetlana; Ernst, Matthias ; Rinaldi, Catherine; Laurent, Geoffrey J; Knight, Darryl A; Fear, Mark; Hoyne, Gerard; McAnulty, Robin J; Mutsaers, Steven E |
| 693 | 28-Jun-2017 | PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation. | Tutuka, Candani S A; Andrews, Miles C; Mariadason, John M ; Ioannidis, Paul; Hudson, Christopher; Cebon, Jonathan S ; Behren, Andreas |
| 694 | 1-Dec-2017 | Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma. | Sznol, Mario; Ferrucci, Pier Francesco; Hogg, David; Atkins, Michael B; Wolter, Pascal; Guidoboni, Massimo; Lebbé, Celeste; Kirkwood, John M; Schachter, Jacob; Daniels, Gregory A; Hassel, Jessica; Cebon, Jonathan S ; Gerritsen, Winald; Atkinson, Victoria; Thomas, Luc; McCaffrey, John; Power, Derek; Walker, Dana; Bhore, Rafia; Jiang, Joel; Hodi, F Stephen; Wolchok, Jedd D |
| 695 | 2-Jan-2024 | Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework. | Korde, Aruna; Patt, Marianne; Selivanova, Svetlana V; Scott, Andrew M ; Hesselmann, Rolf; Kiss, Oliver; Ramamoorthy, Natesan; Todde, Sergio; Rubow, Sietske M; Gwaza, Luther; Lyashchenko, Serge; Andersson, Jan; Hockley, Brian; Kaslival, Ravindra; Decristoforo, Clemens |
| 696 | 1-Oct-2002 | Positron emission tomography and epilepsy. | Casse, Rey; Rowe, Christopher C ; Newton, Mark R; Berlangieri, Salvatore U ; Scott, Andrew M |
| 697 | 18-Oct-2008 | Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study. | Scott, Andrew M ; Gunawardana, Dishan H; Wong, Joseph; Kirkwood, Ian; Hicks, Rodney J; Ho Shon, Ivan; Ramshaw, Jayne E; Robins, Peter |
| 698 | 1-Jul-2004 | Positron emission tomography scanning in the assessment of patients with lymphoma. | Foo, S S; Mitchell, Paul L R ; Berlangieri, Salvatore U ; Smith, C L; Scott, Andrew M |
| 699 | 5-May-2005 | Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer. | Yap, Kelvin K; Byrne, Amanda J; Berlangieri, Salvatore U ; Poon, Aurora M T ; Mitchell, Paul L R ; Knight, Simon R ; Clarke, Peter C; Harris, Anthony H; Tauro, Andrew; Rowe, Christopher C ; Scott, Andrew M |
| 700 | 16-Jan-2024 | Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies. | Lee, Sze Ting ; Kovaleva, Natalia; Senko, Clare ; Kee, Damien ; Scott, Andrew M |
